ZA954077B - Condensed-indan derivatives and pharmaceutically acceptable salts thereof - Google Patents
Condensed-indan derivatives and pharmaceutically acceptable salts thereofInfo
- Publication number
- ZA954077B ZA954077B ZA954077A ZA954077A ZA954077B ZA 954077 B ZA954077 B ZA 954077B ZA 954077 A ZA954077 A ZA 954077A ZA 954077 A ZA954077 A ZA 954077A ZA 954077 B ZA954077 B ZA 954077B
- Authority
- ZA
- South Africa
- Prior art keywords
- group
- substituted
- optionally substituted
- ring
- nitrogenous heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polyesters Or Polycarbonates (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10719094 | 1994-05-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA954077B true ZA954077B (en) | 1996-01-19 |
Family
ID=14452758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA954077A ZA954077B (en) | 1994-05-20 | 1995-05-18 | Condensed-indan derivatives and pharmaceutically acceptable salts thereof |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US5733918A (es) |
| EP (1) | EP0713870B1 (es) |
| KR (1) | KR100190732B1 (es) |
| CN (1) | CN1131216C (es) |
| AT (1) | ATE203236T1 (es) |
| AU (1) | AU685631B2 (es) |
| CA (1) | CA2167382C (es) |
| DE (1) | DE69521770T2 (es) |
| DK (1) | DK0713870T3 (es) |
| ES (1) | ES2158109T3 (es) |
| FI (1) | FI111721B (es) |
| GR (1) | GR3036795T3 (es) |
| HU (1) | HU218308B (es) |
| IL (1) | IL113778A (es) |
| NO (1) | NO305555B1 (es) |
| NZ (1) | NZ285448A (es) |
| PT (1) | PT713870E (es) |
| RU (1) | RU2124017C1 (es) |
| TW (1) | TW440562B (es) |
| WO (1) | WO1995032187A1 (es) |
| ZA (1) | ZA954077B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3141148B2 (ja) * | 1995-08-08 | 2001-03-05 | 大鵬薬品工業株式会社 | 縮合インダン誘導体及びその塩 |
| US6956035B2 (en) * | 2001-08-31 | 2005-10-18 | Inotek Pharmaceuticals Corporation | Isoquinoline derivatives and methods of use thereof |
| US20030096833A1 (en) * | 2001-08-31 | 2003-05-22 | Jagtap Prakash G. | Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
| JP4369229B2 (ja) * | 2001-10-05 | 2009-11-18 | エフ．ホフマン−ラ ロシュ アーゲー | 抗腫瘍活性を有する多環式化合物 |
| US6946472B2 (en) * | 2002-04-30 | 2005-09-20 | Hoffman-La Roche Inc. | Polycyclic compounds exhibiting anti-tumor activities |
| CL2004000366A1 (es) * | 2003-02-26 | 2005-01-07 | Pharmacia Corp Sa Organizada B | USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA. |
| CA2517260A1 (en) * | 2003-02-28 | 2005-02-03 | Inotek Pharmaceuticals Corporation | Tetracyclic benzamide derivatives and methods of use thereof |
| BRPI0508052A (pt) * | 2004-02-26 | 2007-07-17 | Inotek Pharmaceuticals Corp | derivados de lactamo tetracìclico e seus usos |
| KR20060125909A (ko) * | 2004-02-26 | 2006-12-06 | 이노텍 파마슈티컬스 코포레이션 | 이소퀴놀린 유도체 및 이의 사용 방법 |
| AU2005264980A1 (en) * | 2004-06-16 | 2006-01-26 | Inotek Pharmaceuticals Corporation | Methods for treating or preventing erectile dysfunction or urinary incontinence |
| CN101128431B (zh) * | 2005-02-24 | 2011-05-25 | 詹森药业有限公司 | 作为钾离子通道打开剂的喹啉衍生物 |
| AU2006219022A1 (en) * | 2005-02-25 | 2006-09-08 | Inotek Pharmaceuticals Corporation | Isoqunoline Compounds and methods of use thereof |
| US20060287311A1 (en) * | 2005-02-25 | 2006-12-21 | Inotek Pharmaceuticals Corporation | Tetracyclic Sulfonamide Compounds and methods of use thereof |
| JP2008531562A (ja) * | 2005-02-25 | 2008-08-14 | イノテック ファーマシューティカルズ コーポレイション | 四環アミノ化合物および四環カルボキサミド化合物およびこれらの使用法 |
| KR20080039508A (ko) * | 2005-08-24 | 2008-05-07 | 이노텍 파마슈티컬스 코포레이션 | 인데노이소퀴놀리논 유사체 및 이의 사용 방법 |
| AU2008221358A1 (en) * | 2007-02-28 | 2008-09-04 | Inotek Pharmaceuticals Corporation | Indenoisoquinolinone analogs and methods of use thereof |
| CN103102304B (zh) * | 2013-01-19 | 2015-03-11 | 安徽师范大学 | N-磺酰基取代四氢异喹啉衍生物的制备方法 |
| SG11201600759XA (en) | 2013-08-22 | 2016-03-30 | Taiho Pharmaceutical Co Ltd | Novel quinoline-substituted compound |
| JOP20190073A1 (ar) | 2016-10-31 | 2019-04-07 | Taiho Pharmaceutical Co Ltd | مثبط انتقائي لمستقبل عامل نمو بشروي (egfr) لطافر إدخال exon 20 |
| SG11202001861WA (en) | 2017-09-01 | 2020-04-29 | Taiho Pharmaceutical Co Ltd | Selective inhibitor of exon 18 and/or exon 21 mutant egfr |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223506A (en) * | 1991-06-04 | 1993-06-29 | Glaxo Inc. | Cyclic antitumor compounds |
-
1995
- 1995-05-17 TW TW084104882A patent/TW440562B/zh not_active IP Right Cessation
- 1995-05-18 IL IL11377895A patent/IL113778A/xx not_active IP Right Cessation
- 1995-05-18 DE DE69521770T patent/DE69521770T2/de not_active Expired - Fee Related
- 1995-05-18 KR KR1019960700277A patent/KR100190732B1/ko not_active IP Right Cessation
- 1995-05-18 EP EP95918733A patent/EP0713870B1/en not_active Expired - Lifetime
- 1995-05-18 CN CN95190639A patent/CN1131216C/zh not_active Expired - Fee Related
- 1995-05-18 DK DK95918733T patent/DK0713870T3/da active
- 1995-05-18 HU HU9600130A patent/HU218308B/hu not_active IP Right Cessation
- 1995-05-18 NZ NZ285448A patent/NZ285448A/en unknown
- 1995-05-18 ZA ZA954077A patent/ZA954077B/xx unknown
- 1995-05-18 WO PCT/JP1995/000944 patent/WO1995032187A1/ja active IP Right Grant
- 1995-05-18 AU AU24542/95A patent/AU685631B2/en not_active Ceased
- 1995-05-18 AT AT95918733T patent/ATE203236T1/de not_active IP Right Cessation
- 1995-05-18 PT PT95918733T patent/PT713870E/pt unknown
- 1995-05-18 ES ES95918733T patent/ES2158109T3/es not_active Expired - Lifetime
- 1995-05-18 CA CA002167382A patent/CA2167382C/en not_active Expired - Fee Related
- 1995-05-18 US US08/578,542 patent/US5733918A/en not_active Expired - Fee Related
- 1995-05-18 RU RU96105034A patent/RU2124017C1/ru not_active IP Right Cessation
-
1996
- 1996-01-19 FI FI960280A patent/FI111721B/fi active
- 1996-01-19 NO NO960239A patent/NO305555B1/no unknown
- 1996-09-12 US US08/713,224 patent/US5710162A/en not_active Expired - Fee Related
-
1997
- 1997-08-12 US US08/909,934 patent/US6028079A/en not_active Expired - Fee Related
-
2001
- 2001-10-04 GR GR20010401657T patent/GR3036795T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2158109T3 (es) | 2001-09-01 |
| IL113778A0 (en) | 1995-08-31 |
| EP0713870B1 (en) | 2001-07-18 |
| US5710162A (en) | 1998-01-20 |
| US5733918A (en) | 1998-03-31 |
| EP0713870A4 (en) | 1996-12-18 |
| KR960703864A (ko) | 1996-08-31 |
| NO960239D0 (no) | 1996-01-19 |
| DE69521770D1 (de) | 2001-08-23 |
| PT713870E (pt) | 2001-11-30 |
| CA2167382A1 (en) | 1995-11-30 |
| HUT75651A (en) | 1997-05-28 |
| RU2124017C1 (ru) | 1998-12-27 |
| KR100190732B1 (ko) | 1999-06-01 |
| TW440562B (en) | 2001-06-16 |
| IL113778A (en) | 1999-09-22 |
| CA2167382C (en) | 1999-08-31 |
| US6028079A (en) | 2000-02-22 |
| EP0713870A1 (en) | 1996-05-29 |
| ATE203236T1 (de) | 2001-08-15 |
| FI960280A (fi) | 1996-03-18 |
| NZ285448A (en) | 1997-11-24 |
| HU218308B (en) | 2000-07-28 |
| WO1995032187A1 (fr) | 1995-11-30 |
| AU2454295A (en) | 1995-12-18 |
| CN1130903A (zh) | 1996-09-11 |
| AU685631B2 (en) | 1998-01-22 |
| DK0713870T3 (da) | 2001-09-24 |
| DE69521770T2 (de) | 2002-05-23 |
| GR3036795T3 (en) | 2002-01-31 |
| NO960239L (no) | 1996-03-18 |
| CN1131216C (zh) | 2003-12-17 |
| FI111721B (fi) | 2003-09-15 |
| NO305555B1 (no) | 1999-06-21 |
| FI960280A0 (fi) | 1996-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA954077B (en) | Condensed-indan derivatives and pharmaceutically acceptable salts thereof | |
| AU6052594A (en) | New heterocyclic compounds | |
| TW349098B (en) | Naphthalene derivatives, process for the preparation thereof, and intermediates therefor | |
| NO20015448L (no) | Kinolinderivater som inhibitorer av MEK-enzymer | |
| FI956270A0 (fi) | Piperdiinijohdannaisia ja menetelmä niiden valmistamiseksi | |
| FI891700A (fi) | Menetelmä beta-laktaamijohdannaisten valmistamiseksi | |
| MY128323A (en) | Thiazole derivatives for inhibition of cytokine production and of cell adhesion | |
| DE69015541D1 (de) | Chinolinderivate, deren Herstellung und Verwendung. | |
| AU6366386A (en) | 3-vinyl- and 3- ethinyl-beta-carboline derivatives their production and their use as drugs | |
| AU6158486A (en) | Dihydro pyridine derivatives | |
| CA2152817A1 (en) | Novel Pyridone Carboxylic Acid Derivatives | |
| KR950704333A (ko) | 신규한 세펨 유도체(novel cephem derivatives) | |
| EP0785191A4 (en) | INDANE FUSION DERIVATIVES AND THEIR SALTS | |
| DE69634004D1 (de) | Verknüpfte polycyclische heterocyclische verbindungen | |
| DK0466662T3 (da) | 6,7-Disubstituerede-2-aminotetraliner, der er aktive som immunmodulatorer, samt farmaceutiske præparater indeholdende sådanne forbindelser | |
| MX9700497A (es) | Derivado de acido trifluorometilquinolinocarboxilico. | |
| CA2202031A1 (en) | Condensed indan derivatives and salts thereof |